⌘K

Home/Filings/4/0001104659-24-010106

4//SEC Filing

Kelly Steven 4

Accession 0001104659-24-010106

CIK 0001485003other

View on SEC.gov Company Profile

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 4:52 PM ET

Size

5.7 KB

Accession

0001104659-24-010106

Insider Transaction Report

Form 4

Period: 2024-01-31

Carisma Therapeutics Inc.CARM

DirectorPresident and CEO

Transactions

Award
Stock Option (Right to Buy)
2024-01-31+438,000→ 438,000 total
Exercise: $2.10Exp: 2034-01-31→ Common Stock (438,000 underlying)

Footnotes (1)

[F1]The shares underlying this option vest over four years in equal monthly installments, subject to continued service to Carisma Therapeutics Inc. through the applicable vesting date.

Documents

1 file

4
tm245034-1_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Carisma Therapeutics Inc.

CIK 0001485003

Entity typeother

Related Parties

1

filerCIK 0001339478

Filing Metadata

Form type: 4
Filed: Feb 1, 7:00 PM ET
Accepted: Feb 2, 4:52 PM ET
Size: 5.7 KB

View on SEC.gov